Sign In to Follow Application
View All Documents & Correspondence

Anti Infective Composition And Applications Thereof

Abstract: ANTI-INFECTIVE COMPOSITION AND APPLICATIONS THEREOF The present disclosure discloses an anti-infective composition comprising a peptide 1 having an amino sequence as said forth in SEQ ID NO: 1, or derivatives thereof, U@ and a peptide 2 having an amino acid sequence as said forth in SEQ ID NO: 2, or derivatives thereof, wherein the peptide 1 has a weight percentage in a range of 0.003 to 0.0094% with respect to the composition, and the peptide 2 has a weight percentage in a range of 0.0068 to 0.025% with respect to the composition. The composition exhibits the synergistic antimicrobial efficacy against microorganisms. QP@ The present disclosure also discloses a process for preparing the composition.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
29 May 2019
Publication Number
49/2020
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
iprdel@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES & TECHNOLOGY CENTRE #3. 1ST MAIN, PEENYA INDUSTRIAL AREA, PHASE-1, BANGALORE 560 058, INDIA

Inventors

1. JOIS, Prashanth Sirigeri
ITC LSTC, #3, 1st Main, Peenya Industrial Area, 1st Phase, Bangalore-560 058, India
2. KALLUKALAM, Bobby Cherian
ITC LSTC, #3, 1st Main, Peenya Industrial Area, 1st Phase, Bangalore-560 058, India
3. BANDYOPADHYAY, Balaji
ITC LSTC, #3, 1st Main, Peenya Industrial Area, 1st Phase, Bangalore-560 058, India
4. KALSI, Gurpreet
ITC LSTC, #3, 1st Main, Peenya Industrial Area, 1st Phase, Bangalore-560 058, India
5. RAMAMURTHI, Suresh
ITC LSTC, #3, 1st Main, Peenya Industrial Area, 1st Phase, Bangalore-560 058, India
6. CHANDRASEKHARAN, Lakshmanan Chittur
ITC LSTC, #3, 1st Main, Peenya Industrial Area, 1st Phase, Bangalore-560 058, India

Specification

1. An anti-infective composition comprising:
a) a peptide 1 having an amino sequence as said forth in SEQ ID NO: 1 or derivatives thereof; and
b) a peptide 2 having an amino acid sequence as said forth in SEQ ID NO: 2 or derivatives thereof,
wherein the peptide 1 has a weight percentage in a range of 0.003 to 0.0094% with respect to the composition, and the peptide 2 has a weight percentage in a range of 0.0068 to 0.025% with respect to the composition.
2. The anti-infective composition as claimed in claim 1, wherein the peptide 1 has a weight percentage in a range of 0.004 to 0.0085% with respect to the composition.
3. The anti-infective composition as claimed in claim 1, wherein the peptide 2 has a weight percentage in a range of 0.007 to 0.023% with respect to the composition.
4. A process for preparing the anti-infective composition as claimed in claim 1, said process comprising:

a) obtaining the peptide 1;
b) obtaining the peptide 2;
c) obtaining at least one solvent; and
d) contacting the peptide 1, the peptide 2 and the at least one solvent, to obtain the composition.

5. The process for preparing the anti-infective composition as claimed in claim 4, wherein the at least one solvent is selected from a group consisting of water, ethyl alcohol, 2-propanol, 1-propanol, and combinations thereof.
6. The process for preparing the anti-infective composition as claimed in claim 4, wherein contacting the peptide 1, the peptide 2 and the at least one solvent, at a temperature in a range of 20℃- 40℃.
7. The process for preparing the anti-infective composition as claimed in claim 4, wherein the composition has a pH in a range of 4.5 to 7.5.

8. The anti-infective composition as claimed in claim 1, wherein the
composition is effective in reducing growth of at least one type of
microorganism.
9. The anti-infective composition as claimed in claim 8, wherein the at least one
U@ type of microorganism is selected from a group consisting of bacteria, fungi,
parasites, viruses, and combinations thereof.
10. The anti-infective composition as claimed in claim 9, wherein the bacteria is
Pseudomonas aeruginosa.
11. The composition as claimed in anyone of the claims 1-3, wherein the
QP@ composition is in form of at least one substance selected from a group
consisting of antibacterial hand sanitizer, antibacterial hand wash, antibacterial wet wipes, antibacterial spray, antibacterial hand cream, antibacterial lotion, disinfectants, and antiseptics.
12. The composition as claimed in claim 1, wherein the composition further
QU@ comprises at least one excipient selected from a group consisting of aqua,
glycerine, propylene glycol, ethylhexyl glycerine, and combinations thereof.

Documents

Application Documents

# Name Date
1 201941021363-FORM 18 [08-05-2023(online)].pdf 2023-05-08
1 201941021363-STATEMENT OF UNDERTAKING (FORM 3) [29-05-2019(online)].pdf 2019-05-29
2 Correspondence by Agent _Form-1,Power of Attorney_10-07-2019.pdf 2019-07-10
2 201941021363-SEQUENCE LISTING(PDF) [29-05-2019(online)].pdf 2019-05-29
3 201941021363-SEQUENCE LISTING [29-05-2019(online)].txt 2019-05-29
3 201941021363-Proof of Right (MANDATORY) [08-07-2019(online)].pdf 2019-07-08
4 201941021363-FORM-26 [03-07-2019(online)].pdf 2019-07-03
4 201941021363-FORM 1 [29-05-2019(online)].pdf 2019-05-29
5 201941021363-DRAWINGS [29-05-2019(online)].pdf 2019-05-29
5 201941021363-Proof of Right (MANDATORY) [03-07-2019(online)].pdf 2019-07-03
6 201941021363-COMPLETE SPECIFICATION [29-05-2019(online)].pdf 2019-05-29
6 201941021363-DECLARATION OF INVENTORSHIP (FORM 5) [29-05-2019(online)].pdf 2019-05-29
7 201941021363-COMPLETE SPECIFICATION [29-05-2019(online)].pdf 2019-05-29
7 201941021363-DECLARATION OF INVENTORSHIP (FORM 5) [29-05-2019(online)].pdf 2019-05-29
8 201941021363-DRAWINGS [29-05-2019(online)].pdf 2019-05-29
8 201941021363-Proof of Right (MANDATORY) [03-07-2019(online)].pdf 2019-07-03
9 201941021363-FORM 1 [29-05-2019(online)].pdf 2019-05-29
9 201941021363-FORM-26 [03-07-2019(online)].pdf 2019-07-03
10 201941021363-SEQUENCE LISTING [29-05-2019(online)].txt 2019-05-29
10 201941021363-Proof of Right (MANDATORY) [08-07-2019(online)].pdf 2019-07-08
11 Correspondence by Agent _Form-1,Power of Attorney_10-07-2019.pdf 2019-07-10
11 201941021363-SEQUENCE LISTING(PDF) [29-05-2019(online)].pdf 2019-05-29
12 201941021363-STATEMENT OF UNDERTAKING (FORM 3) [29-05-2019(online)].pdf 2019-05-29
12 201941021363-FORM 18 [08-05-2023(online)].pdf 2023-05-08